SS
KPTI icon

Simplicity Solutions’s Karyopharm Therapeutics KPTI Stock Holding History

Simplicity Solutions’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$32.8K Buy
+2,529
New +$34.1K ﹤0.01% 1055
2023
Q3 		– Sell
-1,064
Closed -$28.6K – 1049
2023
Q2 		$28.6K Buy
+1,064
New +$45.8K ﹤0.01% 1040
2016
Q1 		– Sell
-781
Closed -$155K – 359
2015
Q4 		$155K Buy
+781
New +$169K 0.02% 602

Other funds holding KPTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Simplicity Solutions's KPTI Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Karyopharm Therapeutics (KPTI) in Q4 2023: 2,529 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #1055 among its holdings. This is a return to the name: Simplicity Solutions previously reported a position in KPTI as recently as Q2 2023.

Simplicity Solutions first reported a position in KPTI in Q4 2015 and has held it in 3 quarters since. The position peaked at $155K in Q4 2015. 117 funds tracked by Wall St. Rank hold KPTI as of Q4 2023.

  • Simplicity Solutions held 2,529 shares of Karyopharm Therapeutics worth $32.8K as of Q4 2023.
  • Karyopharm Therapeutics was a new Simplicity Solutions position in Q4 2023.
  • Karyopharm Therapeutics made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1055 holding.
  • Simplicity Solutions first reported a position in Karyopharm Therapeutics in Q4 2015 and has held it in 3 quarters since.
  • Simplicity Solutions's Karyopharm Therapeutics position peaked at $155K in Q4 2015.
  • 117 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.